MoonLake Immunotherapeutics
- MLTX
- NASDAQ
- Biotechnology
- Nanobody Therapeutics
- Immunology Biotech
$9.60
Today +0.54%Quote Oct 19, 2026, 01:54 PM UTC
−22.67%over the last month
Max drawdown −28.6%From 1-month high −28.6%3 months −49.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$817.2M
Quote Oct 19
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$50.00
+420.7% from here
Floor
$9.13
5.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MLTXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
130